Synthetic liver-tropic adeno-associated virus capsids and uses thereof

A capsid and capsidization technology, applied in the field of transducing human primary hepatocytes and cell lines, can solve the problem of insufficient liver targeting

Pending Publication Date: 2021-03-26
THE UNIV OF NORTH CAROLINA AT CHAPEL HILL
View PDF41 Cites 10 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Often, modified vectors that exhibit hepatotropism when tested in vitro do not adequately target the liver when used in vivo

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Synthetic liver-tropic adeno-associated virus capsids and uses thereof
  • Synthetic liver-tropic adeno-associated virus capsids and uses thereof
  • Synthetic liver-tropic adeno-associated virus capsids and uses thereof

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0210] Construction of AAV capsid gene shuffling library

[0211]The construction of the AAV capsid gene shuffling library was as previously described (Yang et al., Proc.Natl.Acad.Sci.USA106(10):3946(2009); Yang et al., Meth.Mol.Biol.709:127 (2011)), the capsid genes of AAV serotypes 1, 2, 3B, 4, 6, 7, 8 and 9 were cloned into the same vector pXX-UF1 containing the AAV2 inverted terminal repeat (ITR) and AAV2 Rep gene -AAV. These plasmids containing ITR, AAV2 Rep and each of the eight different Cap genes were named pXX-UF1-AAVn in sequence. These capsid genes were amplified by primers CAP-5'5'-CCC-AAGCTTCGATCAACTACGCAGACAGGTACCAA-3' (SEQ ID NO:7) and CAP-3'5'-ATAAGAAT-GCGGCCGC-AGAGACCAAAGTTCAACTGAAACGA-3' (SEQ ID NO:8). and mixed in the same ratio for DNA shuffling (Stemmer, Proc. Natl. Acad. Sci. USA 91:10747 (1994)). Briefly, 4 μg of DNA template was briefly treated with 0.04 UDNase I at 15°C, and 300–500 and 500–1000 bp fragments were purified from agarose gels using pfu...

example 2

[0213] In vivo enrichment in mouse liver

[0214] For in vivo screening of AAV variants targeting the liver, by 1x10 11 vg (vector genome) / mouse The AAV chimeric library was administered to adult C57BL / 6J mice via the tail vein. After two weeks, mouse tissues, including liver and other tissues, were collected for genomic DNA isolation using phenol / chloroform extraction. After PCR amplification of total liver DNA using universal primers for capsid genes, the PCR products were recloned into an AAV plasmid backbone containing the AAV2 ITR and Rep genes. Therefore, both the capsid gene PCR product and the pXX-UF1-AAV vector were digested with HindIII / NotI and ligated for cloning. A second round of infectious AAV particles was generated from the first round of in vivo enrichment and reinjected into mice. This in vivo enrichment process was repeated three times in mice.

[0215] The final PCR product highly enriched for capsid genes was cloned into a universal precursor of an AA...

example 3

[0217] Generation of AAV vectors containing reporter genes

[0218] Capsid-specific packaging plasmids were prepared by conventional large-scale preparation methods and purified by CsCl density ultracentrifugation twice. These plasmids are used to package reporter genes such as green fluorescent protein GFP and β-galactosidase under the transcriptional control of the ubiquitous promoter CMV or CB (CMV enhancer plus chicken β-actin basal promoter). Lac-Z gene) AAV vector. AAV vectors were packaged in each new capsid and purified by conventional double CsCl density ultracentrifugation. The titer of the reporter vector was determined relative to the known copy number of the corresponding reporter vector plasmid DNA by DNA dot blot. All vector yields were within the normal range.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Dilution degreeaaaaaaaaaa
Login to view more

Abstract

The invention relates to synthetic adeno-associated virus capsids targeted to the liver and virus vectors comprising the same. The invention further relates to methods of using the vectors to target the liver and provide liver-specific expression, as well as transduce human primary hepatocytes and cell lines.

Description

[0001] priority statement [0002] This application claims the benefit of U.S. Provisional Application Serial No. 62 / 683,868, filed June 12, 2018, which is incorporated by reference in its entirety into this application. technical field [0003] The present invention relates to liver-targeting synthetic adeno-associated virus capsids and viral vectors comprising the capsids. The invention further relates to methods of using said vectors to target the liver and provide liver-specific expression and transduction of human primary hepatocytes and cell lines. Background technique [0004] Adeno-associated virus (AAV) has efficient gene transfer and durable transgene expression in various tissues, and thus is a promising in vivo gene therapy vector. AAV vectors have shown good safety and achieved therapeutic effects in gene therapy clinical trials. Several novel AAV serotypes are characterized by greatly improved transduction efficiencies in the heart, muscle, and central nervou...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07K14/005C12N5/071C12N15/86A61K48/00
CPCC07K14/005C12N15/86C12N2750/14143C12N2750/14122C12N2750/14145A61K48/0075C12N5/067A61K48/00C12N2510/00C12N2750/14141C12N2830/008C07K14/015C12N7/00
Inventor 肖啸李娟肖斌袁振华
Owner THE UNIV OF NORTH CAROLINA AT CHAPEL HILL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap